Format

Send to

Choose Destination
JAMA Oncol. 2018 Jul 1;4(7):994-996. doi: 10.1001/jamaoncol.2018.0977.

Total Costs of Chimeric Antigen Receptor T-Cell Immunotherapy.

Author information

1
Department of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania.
2
Center for Pharmaceutical Policy and Prescribing, University of Pittsburgh, Pittsburgh, Pennsylvania.
3
Division of Hematology Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland.
4
Department of Public Health and Preventive Medicine, Oregon Health & Science University, Portland.
5
Center for Health Care Ethics, Oregon Health & Science University, Portland.
6
Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
PMID:
29710129
PMCID:
PMC6145722
[Available on 2019-04-26]
DOI:
10.1001/jamaoncol.2018.0977

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center